Global Point of Care Diagnostics Market 2023-2027

Description

List of Tables

The point of care diagnostics market is forecasted to grow by USD 14,645.04 mn during 2022-2027, accelerating at a CAGR of 10.65% during the forecast period. The report on the point of care diagnostics market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, increased focus on personalized medicine, and growing adoption of automated diagnostic devices in the healthcare industry.

Technavio's point of care diagnostics market is segmented as below:

By Product

Hematology diagnostics
Infectious disease diagnostics
Rapid cardiovascular diagnostics
Rapid coagulation diagnostics
Others

By End-user

Hospitals and clinics
Homecare settings
Clinical diagnostic laboratories

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the shift from conventional testing methods to rapid diagnostics as one of the prime reasons driving the point of care diagnostics market growth during the next few years. Also, technological advances in diagnostics and an increasing number of partnerships and collaborations will lead to sizable demand in the market.

The report on the point of care diagnostics market covers the following areas:

Point of care diagnostics market sizing
Point of care diagnostics market forecast
Point of care diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading point of care diagnostics market vendors that include Abbott Laboratories, altona Diagnostics GmbH, Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Meridian Bioscience Inc., Nova Biomedical Corp., Perkin Elmer Inc., QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Sinocare Inc., Trinity Biotech Plc, Trivida Health Inc., and Zoetis Inc.. Also, the point of care diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR45755

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global point of care diagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global point of care diagnostics market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Hematology diagnostics - Market size and forecast 2022-2027
Exhibit 34: Chart on Hematology diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hematology diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hematology diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hematology diagnostics - Year-over-year growth 2022-2027 (%)
6.4 Infectious disease diagnostics - Market size and forecast 2022-2027
Exhibit 38: Chart on Infectious disease diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Infectious disease diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Infectious disease diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Infectious disease diagnostics - Year-over-year growth 2022-2027 (%)
6.5 Rapid cardiovascular diagnostics - Market size and forecast 2022-2027
Exhibit 42: Chart on Rapid cardiovascular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Rapid cardiovascular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Rapid cardiovascular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Rapid cardiovascular diagnostics - Year-over-year growth 2022-2027 (%)
6.6 Rapid coagulation diagnostics - Market size and forecast 2022-2027
Exhibit 46: Chart on Rapid coagulation diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Rapid coagulation diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Rapid coagulation diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Rapid coagulation diagnostics - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ million)
Exhibit 55: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 58: Chart on Comparison by End-user
Exhibit 59: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 60: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
7.4 Homecare settings - Market size and forecast 2022-2027
Exhibit 64: Chart on Homecare settings - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Homecare settings - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Homecare settings - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Homecare settings - Year-over-year growth 2022-2027 (%)
7.5 Clinical diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 68: Chart on Clinical diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Data Table on Clinical diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Chart on Clinical diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 72: Market opportunity by End-user ($ million)
Exhibit 73: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ million)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key news
Exhibit 126: Abbott Laboratories - Key offerings
Exhibit 127: Abbott Laboratories - Segment focus
12.4 altona Diagnostics GmbH
Exhibit 128: altona Diagnostics GmbH - Overview
Exhibit 129: altona Diagnostics GmbH - Product / Service
Exhibit 130: altona Diagnostics GmbH - Key offerings
12.5 Becton Dickinson and Co.
Exhibit 131: Becton Dickinson and Co. - Overview
Exhibit 132: Becton Dickinson and Co. - Business segments
Exhibit 133: Becton Dickinson and Co. - Key news
Exhibit 134: Becton Dickinson and Co. - Key offerings
Exhibit 135: Becton Dickinson and Co. - Segment focus
12.6 bioMerieux SA
Exhibit 136: bioMerieux SA - Overview
Exhibit 137: bioMerieux SA - Product / Service
Exhibit 138: bioMerieux SA - Key offerings
12.7 Chembio Diagnostics Inc.
Exhibit 139: Chembio Diagnostics Inc. - Overview
Exhibit 140: Chembio Diagnostics Inc. - Product / Service
Exhibit 141: Chembio Diagnostics Inc. - Key offerings
12.8 Danaher Corp.
Exhibit 142: Danaher Corp. - Overview
Exhibit 143: Danaher Corp. - Business segments
Exhibit 144: Danaher Corp. - Key news
Exhibit 145: Danaher Corp. - Key offerings
Exhibit 146: Danaher Corp. - Segment focus
12.9 DiaSorin SpA
Exhibit 147: DiaSorin SpA - Overview
Exhibit 148: DiaSorin SpA - Business segments
Exhibit 149: DiaSorin SpA - Key news
Exhibit 150: DiaSorin SpA - Key offerings
Exhibit 151: DiaSorin SpA - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 152: F. Hoffmann La Roche Ltd. - Overview
Exhibit 153: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 154: F. Hoffmann La Roche Ltd. - Key news
Exhibit 155: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 156: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Perkin Elmer Inc.
Exhibit 157: Perkin Elmer Inc. - Overview
Exhibit 158: Perkin Elmer Inc. - Business segments
Exhibit 159: Perkin Elmer Inc. - Key news
Exhibit 160: Perkin Elmer Inc. - Key offerings
Exhibit 161: Perkin Elmer Inc. - Segment focus
12.12 QIAGEN NV
Exhibit 162: QIAGEN NV - Overview
Exhibit 163: QIAGEN NV - Product / Service
Exhibit 164: QIAGEN NV - Key news
Exhibit 165: QIAGEN NV - Key offerings
12.13 Sekisui Chemical Co. Ltd.
Exhibit 166: Sekisui Chemical Co. Ltd. - Overview
Exhibit 167: Sekisui Chemical Co. Ltd. - Business segments
Exhibit 168: Sekisui Chemical Co. Ltd. - Key offerings
Exhibit 169: Sekisui Chemical Co. Ltd. - Segment focus
12.14 Siemens AG
Exhibit 170: Siemens AG - Overview
Exhibit 171: Siemens AG - Business segments
Exhibit 172: Siemens AG - Key news
Exhibit 173: Siemens AG - Key offerings
Exhibit 174: Siemens AG - Segment focus
12.15 Sinocare Inc.
Exhibit 175: Sinocare Inc. - Overview
Exhibit 176: Sinocare Inc. - Product / Service
Exhibit 177: Sinocare Inc. - Key news
Exhibit 178: Sinocare Inc. - Key offerings
12.16 Trinity Biotech Plc
Exhibit 179: Trinity Biotech Plc - Overview
Exhibit 180: Trinity Biotech Plc - Product / Service
Exhibit 181: Trinity Biotech Plc - Key offerings
12.17 Zoetis Inc.
Exhibit 182: Zoetis Inc. - Overview
Exhibit 183: Zoetis Inc. - Business segments
Exhibit 184: Zoetis Inc. - Key news
Exhibit 185: Zoetis Inc. - Key offerings
Exhibit 186: Zoetis Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 187: Inclusions checklist
Exhibit 188: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 189: Currency conversion rates for US$
13.4 Research methodology
Exhibit 190: Research methodology
Exhibit 191: Validation techniques employed for market sizing
Exhibit 192: Information sources
13.5 List of abbreviations
Exhibit 193: List of abbreviations